Keine Story von Zhejiang Hisun Pharmaceutical Co. Ltd mehr verpassen.

Zhejiang Hisun Pharmaceutical Co. Ltd

  • 22.06.2020 – 12:49

    Hisun Pharmaceutical: Free of COVID-19, Governments Suggest Favipiravir

    Taizhou, China (ots/PRNewswire) - Favipiravir is a broad-spectrum antiviral agent that inhibits the RNA-dependent RNA polymerase of RNA viruses. It has efficacy against a range of RNA viruses, including Ebola, influenza and COVID-19. No evident adverse reactions have been found since it came into the market. Unlike traditional antiviral drugs, Favipiravir can directly ...